Vivaldi Capital Management’s CME Group CME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-2,503
| Closed | -$739K | – | 40 |
|
|
2026
Q1 | $739K | Sell |
2,503
-79
| -3% | -$23.5K | 0.1% | 125 |
|
|
2025
Q4 | $705K | Hold |
2,582
| – | – | 0.1% | 127 |
|
|
2025
Q3 | $698K | Buy |
2,582
+8
| +0.3% | +$2.18K | 0.1% | 126 |
|
|
2025
Q2 | $709K | Buy |
2,574
+25
| +1% | +$6.8K | 0.11% | 127 |
|
|
2025
Q1 | $676K | Buy |
2,549
+4
| +0.2% | +$987 | 0.11% | 123 |
|
|
2024
Q4 | $603K | Sell |
2,545
-64
| -2% | -$14.7K | 0.09% | 129 |
|
|
2024
Q3 | $576K | Sell |
2,609
-107
| -4% | -$22.1K | 0.17% | 103 |
|
|
2024
Q2 | $534K | Sell |
2,716
-3
| -0.1% | -$620 | 0.15% | 115 |
|
|
2024
Q1 | $567K | Buy |
2,719
+451
| +20% | +$94.7K | 0.17% | 112 |
|
|
2023
Q4 | $470K | Sell |
2,268
-182
| -7% | -$38.8K | 0.14% | 129 |
|
|
2023
Q3 | $491K | Sell |
2,450
-330
| -12% | -$65.6K | 0.16% | 108 |
|
|
2023
Q2 | $515K | Buy |
2,780
+108
| +4% | +$20K | 0.16% | 105 |
|
|
2023
Q1 | $512K | Sell |
2,672
-115
| -4% | -$20.8K | 0.15% | 110 |
|
|
2022
Q4 | $490K | Buy |
2,787
+10
| +0.4% | +$1.74K | 0.12% | 140 |
|
|
2022
Q3 | $472K | Buy |
2,777
+13
| +0.5% | +$2.57K | 0.13% | 121 |
|
|
2022
Q2 | $566K | Sell |
2,764
-7
| -0.3% | -$1.48K | 0.15% | 116 |
|
|
2022
Q1 | $554K | Buy |
2,771
+5
| +0.2% | +$1.17K | 0.14% | 121 |
|
|
2021
Q4 | $632K | Buy |
2,766
+2
| +0.1% | +$440 | 0.15% | 105 |
|
|
2021
Q3 | $535K | Hold |
2,764
| – | – | 0.12% | 123 |
|
|
2021
Q2 | $572K | Sell |
2,764
-21
| -0.8% | -$4.43K | 0.11% | 126 |
|
|
2021
Q1 | $604K | Sell |
2,785
-54
| -2% | -$10.6K | 0.12% | 126 |
|
|
2020
Q4 | $517K | Sell |
2,839
-1,720
| -38% | -$293K | 0.11% | 140 |
|
|
2020
Q3 | $757K | Sell |
4,559
-24
| -0.5% | -$4.04K | 0.17% | 111 |
|
|
2020
Q2 | $779K | Buy |
4,583
+194
| +4% | +$34.8K | 0.16% | 102 |
|
|
2020
Q1 | $759K | Sell |
4,389
-940
| -18% | -$187K | 0.17% | 93 |
|
|
2019
Q4 | $1.06M | Sell |
5,329
-4,102
| -43% | -$842K | 0.26% | 74 |
|
|
2019
Q3 | $1.99M | Buy |
9,431
+2,111
| +29% | +$441K | 0.47% | 49 |
|
|
2019
Q2 | $1.42M | Sell |
7,320
-3,848
| -34% | -$709K | 0.37% | 59 |
|
|
2019
Q1 | $1.84M | Buy |
11,168
+8,245
| +282% | +$1.46M | 0.51% | 56 |
|
|
2018
Q4 | $550K | Buy |
+2,923
| New | +$540K | 0.24% | 83 |
|
Other funds holding CME
Vivaldi Capital Management's CME Position: Q2 2026 in Review
Vivaldi Capital Management sold out of CME Group (CME) in Q2 2026, closing a stake of 2,503 shares — an estimated $739K sold.
Vivaldi Capital Management first reported a position in CME in Q4 2018 and held it in 30 quarters. The position peaked at $1.99M in Q3 2019. 1,698 funds tracked by Wall St. Rank hold CME as of Q2 2026.
- Vivaldi Capital Management reported no remaining CME Group position as of Q2 2026 after selling out during the quarter.
- Vivaldi Capital Management sold 2,503 CME Group shares in Q2 2026, an estimated $739K.
- Vivaldi Capital Management first reported a position in CME Group in Q4 2018 and held it in 30 quarters.
- Vivaldi Capital Management's CME Group position peaked at $1.99M in Q3 2019.
- 1,698 funds tracked by Wall St. Rank held CME Group as of Q2 2026.
Based on Vivaldi Capital Management's 13F filing for Q2 2026.